Sustained low levels of IFN-γ increase the expression of molecules involved in tumor immune evasion, including programmed death-1 ligand 1 (PD-L1) and 2 (PD-L2) and cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) [23]. The gene discussed is IFNG; the disease is neoplasm.